Article
p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
PloS one - 1 Jan 2012
Weng Yu, Lu Liqin, Yuan Guorong, Guo Jing, Zhang Zhizhong, Xie Xinyou, Chen Guangdi, Zhang Jun
Abstract excerpt
BACKGROUND: Previous studies on the association of p53 codon 72 (Arg72Pro) polymorphism with hematological malignancies risk have produced conflicting results. The purpose of this meta-analysis is to define the effect of p53 Arg72Pro polymorphism on hematological malignancies risk. METHODOLOGY/PRINCIPAL FINDINGS: Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
